PRA International Extends Operations Into New Zealand

RALEIGH, N.C., April 19 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces it has established a legal entity and hired staff in New Zealand, which will complement the firm's extensive network of Asia-Pacific operations and partnerships.

PRA can now monitor New Zealand study sites with in-country staff.  This local presence, combined with PRA's continued expansion in the region, further enhances its position as a CRO gateway to the world's most rapidly expanding clinical research environment. New Zealand is a key research location for studies in skin cancer, multiple sclerosis, asthma and several other conditions.

PRA's New Zealand staff will work closely with employees in the PRA Sydney, Australia office. This presents an ideal situation for collaboration, since the countries share similar healthcare and clinical research environments. In addition, companies frequently conduct clinical trials simultaneously across Australia and New Zealand, and their health specialists are linked through joint professional associations and research organizations.

A strategic location for expansion, New Zealand offers the following advantages:

• Traditionally high recruitment rates across major therapeutic areas, such cardiology, respiratory and gastrointestinal
• Efficient regulatory environment
• Counter seasonality (e.g., influenza studies can be commenced/continued through the northern hemisphere spring/summer, and allergy studies through the northern autumn/winter)

"We are very pleased with the expansion to New Zealand," noted Edward Ian, PRA's Senior Director of Operations for Asia-Pacific.  "It continues our expansion in this critical region and is an ideal complement to our operations in Australia."

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 2,700 clinical trials through its 37 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email [email protected] or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED